Behavior Imaging®: Resolving Assessment Challenges for Autism Spectrum Disorder in Pharmaceutical Trials
Contribution to Books
Behavior Imaging® was incorporated into an NIMH-funded multisite pharmaceutical trial to remotely document clinical rater reliability within a standardized observer evaluation protocol. Behavior Imaging provided a centralized telehealth system capable of documenting observer agreement. Interviewer-observer training and ongoing maintenance of assessment quality was performed efficiently. Behavior Imaging provided an important new quality control tool previously not available for such multisite research studies. The results indicate the potential for successful applications also to retrospective studies of archived video data and the evaluation of recorded data obtained in natural settings.
Oberleitner, Ron; Reischl, Uwe; Gazieva, Kamilla G.; Nazneen, N.; Suri, Jasjit S.; and Smith, Christopher J.. (2017). "Behavior Imaging®: Resolving Assessment Challenges for Autism Spectrum Disorder in Pharmaceutical Trials". Autism Imaging and Devices, 355-370.